Assignee
TENEOBIO INC
US·11 granted patents·30 pending applications·22 citations·filing 2017–2025
Top patents by PatentIndex Score
41 records- 0192US11505606B2CD3 binding antibodiesTENEOBIO INC·Filed 2017·Granted Nov 22, 2022·10 cites·30 claims
- 0286US11613572B2CD3 binding antibodiesTENEOBIO INC·Filed 2017·Granted Mar 28, 2023·4 cites·13 claims
- 0386US11434299B2Anti-BCMA heavy chain-only antibodiesTENEOBIO INC·Filed 2017·Granted Sep 6, 2022·4 cites·17 claims
- 0484US11884735B2Agonistic anti-IL-2R antibodies and methods of useTENEOBIO INC·Filed 2023·Granted Jan 30, 2024·2 cites·25 claims
- 0583US2026085115A1Cd3 binding antibodiesTENEOBIO INC·Filed 2025·Application pending·0 cites
- 0682US11905326B2Multispecific heavy chain antibodies binding to CD22 and CD3TENEOBIO INC·Filed 2020·Granted Feb 20, 2024·2 cites·97 claims
- 0779US2023272075A1Cd3 binding antibodiesTENEOBIO INC·Filed 2022·Application pending·0 cites
- 0877US2024117050A1Cd3-delta/epsilon heterodimer specific antibodiesTENEOBIO INC·Filed 2023·Application pending·0 cites
- 0976US12371505B2Anti-BCMA heavy chain-only antibodiesTENEOBIO INC·Filed 2022·Granted Jul 29, 2025·0 cites·10 claims
- 1074US2025236681A1Heavy chain antibodies binding to psmaTENEOBIO INC·Filed 2024·Application pending·0 cites
- 1174US2026090529A1Transgenic non-human animals producing modified heavy chain-only antibodiesTENEOBIO INC·Filed 2025·Application pending·0 cites
- 1272US2023203161A1Multispecific heavy chain antibodies with modified heavy chain constant regionsTENEOBIO INC·Filed 2021·Application pending·0 cites
- 1371US2024124599A1Anti-bcma heavy chain-only antibodiesTENEOBIO INC·Filed 2023·Application pending·0 cites
- 1471US2025197497A1Methods for purifying heterodimeric, multispecific antibodiesTENEOBIO INC·Filed 2025·Application pending·0 cites
- 1568US2023242668A1Heavy chain antibodies binding to psmaTENEOBIO INC·Filed 2023·Application pending·0 cites
- 1668US2024018235A1Cd3 binding antibodiesTENEOBIO INC·Filed 2023·Application pending·0 cites
- 1767US2024117046A1Heavy chain antibodies binding to cd22TENEOBIO INC·Filed 2023·Application pending·0 cites
- 1867US2025179180A1Cd3-delta/epsilon heterodimer specific antibodiesTENEOBIO INC·Filed 2025·Application pending·0 cites
- 1966US2024368274A1Multispecific heavy chain antibodies binding to cd22 and cd3TENEOBIO INC·Filed 2024·Application pending·0 cites
- 2065US2025270337A1Anti-bcma heavy chain-only antibodiesTENEOBIO INC·Filed 2025·Application pending·0 cites
- 2165US2024117063A1Anti-cd20 antibodies and car-t structuresTENEOBIO INC·Filed 2023·Application pending·0 cites
- 2265US2024042032A1Anti-cd19 antibodies and car-t structuresTENEOBIO INC·Filed 2023·Application pending·0 cites
- 2365US2020339685A1Cd3-delta/epsilon heterodimer specific antibodiesTENEOBIO INC·Filed 2018·Application pending·0 cites
- 2464US12590163B2Agonistic anti-IL-2R antibodies and methods of useTENEOBIO INC·Filed 2023·Granted Mar 31, 2026·0 cites·24 claims
- 2562US12180298B2Heavy chain antibodies binding to PSMATENEOBIO INC·Filed 2020·Granted Dec 31, 2024·0 cites·28 claims
- 2662US2026048122A1Anti-cd19 antibodies and car-t structuresTENEOBIO INC·Filed 2025·Application pending·0 cites
- 2761US2025346682A1Anti-cd20 antibodies and car-t structuresTENEOBIO INC·Filed 2025·Application pending·0 cites
- 2859US11970540B2Anti-BCMA heavy chain-only antibodiesTENEOBIO INC·Filed 2018·Granted Apr 30, 2024·0 cites·14 claims
- 2959US2021355215A1Methods for purifying heterodimeric, multispecific antibodiesTENEOBIO INC·Filed 2019·Application pending·0 cites
- 3057US11873336B2Heavy chain antibodies binding to CD22TENEOBIO INC·Filed 2018·Granted Jan 16, 2024·0 cites·14 claims
- 3156US2025367237A1C-kit binding proteins, chimeric antigen receptors, and uses thereofTENEOBIO INC·Filed 2025·Application pending·0 cites
- 3256US2026035478A1Mesothelin binding proteins and uses thereofTENEOBIO INC·Filed 2023·Application pending·0 cites
- 3355US2024002498A1Heavy chain antibodies binding to folate receptor alphaTENEOBIO INC·Filed 2021·Application pending·0 cites
- 3455US2024226162A9Anti-psma antibodies and car-t structuresTENEOBIO INC·Filed 2022·Application pending·0 cites
- 3555US2023257473A1Multi-specific antibodies binding to bcmaTENEOBIO INC·Filed 2021·Application pending·0 cites
- 3651US12495776B2Transgenic non-human animals producing modified heavy chain-only antibodiesTENEOBIO INC·Filed 2017·Granted Dec 16, 2025·0 cites·14 claims
- 3750US2023192843A1Mesothelin binding proteins and uses thereofTENEOBIO INC·Filed 2022·Application pending·0 cites
- 3850US2024182597A1Anti-muc1-c antibodies and car-t structuresTENEOBIO INC·Filed 2022·Application pending·0 cites
- 3947US2021403587A1Methods of treating multiple myelomaTENEOBIO INC·Filed 2021·Application pending·0 cites
- 4045US2021388106A1Heavy chain antibodies binding to cd38TENEOBIO INC·Filed 2019·Application pending·0 cites
- 4141US2020207867A1Heavy chain antibodies binding to ectoenzymesTENEOBIO INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TENEOBIO INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →